Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukopheresis”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Testing effectiveness (Phase 2)Study completedNCT03610724
What this trial is testing

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Who this might be right for
Non-Hodgkin Lymphoma
Novartis Pharmaceuticals 34
Early research (Phase 1)Study completedNCT02208167
What this trial is testing

Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy

Who this might be right for
HIV
University of North Carolina, Chapel Hill 6
Not applicableLooking for participantsNCT01212055
What this trial is testing

Apheresis of Patients With Immunodeficiency

Who this might be right for
LAD-1DOCK8GATA2 Deficancy
National Cancer Institute (NCI) 7
Early research (Phase 1)Study completedNCT02375256
What this trial is testing

A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402

Who this might be right for
Tuberculosis
Aeras 11
Not applicableStudy completedNCT00333892
What this trial is testing

Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients

Who this might be right for
Human Immunodeficiency Virus
Canadian Immunodeficiency Research Collaborative 220
Testing effectiveness (Phase 2)Ended earlyNCT03709706
What this trial is testing

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

Who this might be right for
Neoplasms
GlaxoSmithKline 34
Early research (Phase 1)Study completedNCT00011830
What this trial is testing

Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission

Who this might be right for
Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 20
Not applicableEnded earlyNCT02447926
What this trial is testing

Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies

Who this might be right for
End Stage Liver Disease
Northwestern University 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03967223
What this trial is testing

Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors

Who this might be right for
Neoplasms
USWM CT, LLC 103
Not applicableLooking for participantsNCT00571389
What this trial is testing

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Who this might be right for
Solid Tumor, AdultHealthy DonorsCOVID-19 Donors
BioCytics, Inc. 1,500
Large-scale testing (Phase 3)Study completedNCT00040235
What this trial is testing

Magnesium Effects in Apheresis

Who this might be right for
Healthy
National Institutes of Health Clinical Center (CC) 52
Early research (Phase 1)Study completedNCT01416974
What this trial is testing

Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00011505
What this trial is testing

Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia

Who this might be right for
Diamond Blackfan Anemia
National Heart, Lung, and Blood Institute (NHLBI) 15
Early research (Phase 1)Study completedNCT00000680
What this trial is testing

A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Not applicableLooking for participantsNCT07491328
What this trial is testing

Liquid Biopsy in Paraneoplastic Neurological Syndromes

Who this might be right for
Paraneoplastic Neurological Syndromes
Heinrich-Heine University, Duesseldorf 60
Not applicableStudy completedNCT03517917
What this trial is testing

Prospective Tissue Collection Research Protocol

Who this might be right for
Solid Tumor
AstraZeneca 221
Testing effectiveness (Phase 2)UnknownNCT00131560
What this trial is testing

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

Who this might be right for
HIV Infection
VIRxSYS Corporation 60
Early research (Phase 1)Looking for participantsNCT05003895
What this trial is testing

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerMetastatic Hepatocellular Carcinoma
National Cancer Institute (NCI) 38
Not applicableLooking for participantsNCT01161199
What this trial is testing

The Use of Leukapheresis to Support HIV Pathogenesis Studies

Who this might be right for
HIV
University of California, San Francisco 100
Not applicableEnded earlyNCT01200823
What this trial is testing

Collection of Blood, Bone Marrow, Leukapheresis, and Tissue Biopsy Samples From Patients and Their Family Members for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases Laboratory Research Studies

Who this might be right for
Idopathic Inflammatory/Autoimmune Syndromes
National Institute of Allergy and Infectious Diseases (NIAID) 96
Next Page